Author:
Kowalska Justyna D.,Ankiersztejn-Bartczak Magdalena,Shepherd Leah,Mocroft Amanda
Funder
Research Development Foundation, Hospital for Infectious Diseases in Warsaw
Gilead Sciences Poland
Abbvie Poland
GlaxoSmithKline Poland
ViiV Healthcare
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference32 articles.
1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.
2. Kowalska JD, Wojcik G, Rutkowski J, Ankiersztejn-Bartczak M, Siewaszewicz E. Modelling the cost-effectiveness of HIV care shows a clear benefit when transmission risk is considered in the calculations—a message for Central and Eastern Europe. PLoS One. 2017;12:e0186131.
3. UN AIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. http://www.unaids.org/sites/default/files/media_asset/90-90-90_en_0.pdf Accessed 16 Nov 2016.
4. Parczewski M, Siwak E, Leszczyszyn-Pynka M, Cielniak I, Burkacka E, Pulik P, et al. Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics. J Int AIDS Soc. 2017;20:21847.
5. ECDC. Thematic report: HIV continuum of care. Available at: http://ecdc.europa.eu/en/publications/publications/dublin-declaration-continuum-of-care-2014.pdf . Accessed on 25 November 2016.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献